Tax on Share Settlement
Vertex Pharmaceuticals Tax on Share Settlement decreased by 97.3% to $2.50M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 65.8%, from $7.30M to $2.50M. Over 4 years (FY 2021 to FY 2025), Tax on Share Settlement shows an upward trend with a 28.4% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Analysis
How to read this metric
Increases generally track with rising stock prices or larger employee equity grants, reflecting the cost of maintaining a share-based incentive program.
Detailed definition
Cash outflows related to the withholding of taxes on behalf of employees during the settlement of share-based compensati...
Peer comparison
Common in Silicon Valley and high-growth tech firms where equity is a primary component of total compensation.
cf_taxes_paid_for_sharesHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $3.52M | $28.56M | $1.68M | $117.50M | $4.40M | $48.00M | $2.10M | $166.60M | $3.10M | $53.20M | $3.20M | $233.50M | $80.50M | $83.70M | $7.30M | $270.50M | $5.90M | $91.00M | $2.50M |
| QoQ Change | — | +710.4% | -94.1% | >999% | -96.3% | +990.9% | -95.6% | >999% | -98.1% | >999% | -94.0% | >999% | -65.5% | +4.0% | -91.3% | >999% | -97.8% | >999% | -97.3% |
| YoY Change | — | — | — | — | +24.9% | +68.1% | +25.2% | +41.8% | -29.5% | +10.8% | +52.4% | +40.2% | >999% | +57.3% | +128.1% | +15.8% | -92.7% | +8.7% | -65.8% |
Tax on Share Settlement at Other Companies
Frequently Asked Questions
- What is Vertex Pharmaceuticals's tax on share settlement?
- Vertex Pharmaceuticals (VRTX) reported tax on share settlement of $2.50M in Q4 2025.
- How has Vertex Pharmaceuticals's tax on share settlement changed year-over-year?
- Vertex Pharmaceuticals's tax on share settlement decreased by 65.8% year-over-year, from $7.30M to $2.50M.
- What is the long-term trend for Vertex Pharmaceuticals's tax on share settlement?
- Over 4 years (2021 to 2025), Vertex Pharmaceuticals's tax on share settlement has grown at a 28.4% compound annual growth rate (CAGR), from $135.90M to $369.90M.
- What does tax on share settlement mean?
- The cash a company pays to the government to cover taxes on employee stock bonuses.